Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak Risks in Pig Farms
Press Release

Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak Risks in Pig Farms

BANGKOK, Aug. 31, 2026 /PRNewswire/ — Researchers from Chulalongkorn University‘s Faculty of Veterinary Science have developed synthetic boar scent mimicking natural pheromones, providing a safer way to stimulate reproduction while reducing the risk of disease transmission associated with direct contact between breeding animals. Chula Researchers Develop Synthetic Boar Scent Mimicking Natural Pheromones to Reduce Disease Outbreak […]

Read More
Dowinx Reframes Everyday Seating Around the Way People Really Live
Press Release

Dowinx Reframes Everyday Seating Around the Way People Really Live

The QL-66B6 Executive Office Chair brings adaptive comfort to hybrid spaces for work, gaming and relaxation HONG KONG and LOS ANGELES, Aug. 31, 2026 /PRNewswire/ — As the consumer technology industry looks toward IFA 2026 and the future of connected living, Dowinx is focusing on a more human question: how should seating respond when work, play […]

Read More
LG ELECTRONICS UNVEILS THE NEXT EVOLUTION OF AI HOME AT IFA 2026
Press Release

LG ELECTRONICS UNVEILS THE NEXT EVOLUTION OF AI HOME AT IFA 2026

Introducing ThinQ Claw and Expanded AI Home Experiences Powered by Contextual Intelligence News Summary LG unveils the next evolution of AI Home at IFA 2026, leveraging upgraded contextual intelligence to recommend relevant actions, coordinate connected devices and services, and deliver a more personalized experience. The brand-new ThinQ Claw introduces text-chat-based interactions to AI Home, comprehending […]

Read More
AU10TIX and NEO Partner to Bring Real-Time Identity Verification to High-Volume Venues
Press Release

AU10TIX and NEO Partner to Bring Real-Time Identity Verification to High-Volume Venues

Partnership helps gaming, wagering, hospitality, and travel operators automate identity checks, reduce manual review, and accelerate compliant self-service experiences MELBOURNE, Australia, Aug. 31, 2026 /PRNewswire/ — AU10TIX, a global identity verification and fraud intelligence company trusted by enterprises worldwide, today announced a partnership with NEO, a leading global provider of self-service terminal technology and automation […]

Read More
NUS-ISS Learning Festival 2026 addresses key blockers to enterprise AI: data readiness, governance, and workforce capability
Press Release

NUS-ISS Learning Festival 2026 addresses key blockers to enterprise AI: data readiness, governance, and workforce capability

From expert keynotes and practical workshops to a hackathon, this year’s festival equips participants with practical insights to move from AI pilots to enterprise-grade deployment SINGAPORE, Aug. 31, 2026 /PRNewswire/ — NUS-ISS has launched the 11th edition of its flagship Learning Festival, a six-week series running from 28 August to 10 October 2026. Marking its […]

Read More
Amai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products
Press Release

Amai Proteins' sweelin® Approved for Sale in Israel, Opening the Market to a New Generation of Reduced-Sugar Food and Beverage Products

Third regulatory approval in less than six months enables food and beverage manufacturers to commercialize products sweetened with sweelin® in Israel. REHOVOT, Israel, Aug. 31, 2026 /PRNewswire/ — Amai Proteins announces that the Israeli Ministry of Health has officially approved sweelin® as a novel food ingredient for use in a broad range of food and […]

Read More
Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore
Press Release

Subsidised Access to Columvi® Now Available for Eligible Patients with Relapsed or Refractory DLBCL in Singapore

Columvi (glofitamab) will be added to the Cancer Drug List (CDL) and Medication Assistance Fund (MAF) on 1 September 2026 for eligible patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) who are not candidates for autologous stem cell transplant and have received at least one prior therapy.[1] This inclusion expands treatment options for […]

Read More
WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
Press Release

WuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion

SHANGHAI, Aug. 31, 2026 /PRNewswire/ — WuXi AppTec Co., Ltd. (Stock Codes: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), announces the distribution of its 2026 interim cash dividend. Building on its inaugural interim dividend of RMB 1.03 billion in 2025, the Company has further increased its 2026 interim dividend payout […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.